N. Regina Rabinovich
ExxonMobil Malaria Scholar in Residence
Dr. N. Regina Rabinovich is a global health leader with over 25 years’ experience in the research, public health, and philanthropic sectors, with focus on strategy, analytics, global health product development, and the introduction and scale-up of tools and strategies resulting in impact on endemic populations. Since 2012, she has served as the ExxonMobil Malaria Scholar in Residence at Harvard University.
From 2003-2012, she was Director of the Infectious Diseases Unit at the Bill & Melinda Gates Foundation where she oversaw the development and implementation of strategies for the prevention, treatment, and control of diseases of particular relevance to global health, including malaria, pneumonia, diarrhea, and neglected infectious diseases.
During her tenure at the U.S. National Institute of Allergy and Infectious Diseases (NIAID), she helped develop and evaluate vaccines. In addition to participating in the Children’s Vaccine Initiative and liaising on issues related to vaccine safety and vaccine research, she managed the evaluation of candidate vaccines through a network of U.S. clinical research units. During her time as Director of the PATH Malaria Vaccine Initiative, she advanced efforts to develop promising malaria vaccine candidates.
She serves on the boards of the NIAID Council, National Institutes of Health Council on Councils, PATH Vaccine Solutions, AERAS, and Harvard University’s Defeating Malaria: From the Genes to the Globe initiative. Dr. Rabinovich holds a medical degree from Southern Illinois University and a Masters of Public Health degree from the University of North Carolina.
M.P.H., 1988, University of North Carolina
M.D., 1982, S. Illinois University
B.A., 1976, University of Iowa